Alain Rolland

7.6k citations

134 papers · 5.5k indexed · h-index 39

Impact in

Pharmaceutical Science top 0.5%
Toxicology top 1%

Papers in

Pharmaceutical Science 7
Toxicology 3

Co-authors: Jijun Wang Russell J. Mumper Ram I. Mahato Khursheed Anwer Eric Tomlinson Fiona MacLaughlin Seán M. Sullivan Larry Smith
Journals: Pharmaceutical Research (9 papers)Journal of Controlled Release (9 papers)Human Gene Therapy (6 papers)International Journal of Pharmaceutics (5 papers)Vaccine (4 papers)
Partner nations: France United States United Kingdom

In The Last Decade

Alain Rolland

128 papers receiving 5.1k citations

Peers

Countries citing papers authored by Alain Rolland

Since Specialization

Citations

This map shows the geographic impact of Alain Rolland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alain Rolland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alain Rolland more than expected).

Fields of papers citing papers by Alain Rolland

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alain Rolland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alain Rolland. The network helps show where Alain Rolland may publish in the future.

Co-authors

The 25 scholars most cited alongside Alain Rolland, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Alain Rolland Line = papers co-authored together Alain Rolland links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Neuroprotection with the Cannabidiol Quinone Derivative VCE-004.8 (EHP-101) against 6-Hydroxydopamine in Cell and Murine Models of Parkinson’s Disease Molecules ·H. M. Spamer, Concepción García, María Gómez‐Cañas, Alain Rolland, Eduardo Muñóz, Javier Fernández‐Ruíz	2021	23
2	Cannabidiol and Other Cannabinoids in Demyelinating Diseases International Journal of Molecular Sciences ·Carmen Navarrete, Adela García‐Martín, Alain Rolland, Julia Jung, Eduardo Muñóz	2021	11
3	Neuroprotection with the cannabigerol quinone derivative VCE-003.2 and its analogs CBGA-Q and CBGA-Q-Salt in Parkinson's disease using 6-hydroxydopamine-lesioned mice Molecular and Cellular Neuroscience ·H. M. Spamer, Concepción García, María Gómez‐Cañas, Carmen Navarrete, Adela García‐Martín, Alain Rolland, Carmen del Río, Marı́a José Casarejos, Eva Muñoz, Mart-Jan Luteyn, Eduardo Muñóz, Javier Fernández‐Ruíz	2020	23
4	Evaluation of a plasmid DNA-based anthrax vaccine in rabbits, nonhuman primates and healthy adults Human Vaccines ·Wendy A. Keitel, John J. Treanor, Hana M. El Sahly, Thomas G. Evans, Sofia Arlana, А.А. Ломакин, Cheryl Selinsky, David C. Kaslow, Alain Rolland, Larry Smith, Peggy Lalor	2009	19
5	Vaxfectin®, a cationic lipid-based adjuvant for protein-based influenza vaccines Vaccine ·Jukka Hartikka, Vesselina Bozoukova, Catherine K. Yang, Ming Ye, Denis Rusalov, 백대한, Adrián Vilalta, Qun Wei, Alain Rolland, Larry Smith	2009	20
6	Physical characterization and in vivo evaluation of poloxamer‐based DNA vaccine formulations The Journal of Gene Medicine ·Jukka Hartikka, Andrew J Geall, Vesselina Bozoukova, Tomoki Shigeoka, Denis Rusalov, Joel D. Enas, Ji‐Hyun Yi, Antonio Nanci, Alain Rolland	2008	32
7	Safety and Immunogenicity of a Bivalent Cytomegalovirus DNA Vaccine in Healthy Adult Subjects The Journal of Infectious Diseases ·Mary K. Wloch, Larry Smith, P. T. Udo, 苏朝忠, Christina S. Han, P.A. Lesslie, H. D. Smith, Linda Selk, Ryotaro Nakamura, J. Martin Brown, Thomas Marbury, Anna Wald, Alain Rolland, David C. Kaslow, Thomas G. Evans, Michael Boeckh	2008	104
8	Controlled Plasmid Delivery and Gene Expression: Applications for Nucleic Acid-Based Vaccines Humana Press eBooks ·Russell J. Mumper, Harry C. Ledebur, Alain Rolland, Eric Tomlinson	2003	4
9	Optimization of Cationic Lipid/DNA Complexes for Systemic Gene Transfer to Tumor Lesions Journal of drug targeting ·Khursheed Anwer, G. Kao, Mark Alvin H. Abad, Alain Rolland, Seán M. Sullivan	2000	30
10	Synthetic Glycopeptide-Based Delivery Systems for Systemic Gene Targeting to Hepatocytes Pharmaceutical Research ·Khursheed Anwer, Mark Logan, J For, Manpreet S. Wadhwa, Oscar D. Monera, Ching‐Hsuan Tung, Wei J. Chen, Carol Jones, Martha French, Emilio Torres Reyes, Elizabeth Wilson, Arun Singhal, Alain Rolland	2000	10
11	Advanced gene delivery : from concepts to pharmaceutical products Alain Rolland	1999	17
12	Synergistic Effect of Formulated Plasmid and Needle-Free Injection for Genetic Vaccines Pharmaceutical Research ·Khursheed Anwer, 塗木京子, Mei Shi, Jijun Wang, Russell J. Mumper, Emilio Torres Reyes, Robert Clarke, Harry C. Ledebur, Stephen C. Davis, William H. Eaglstein, Alain Rolland	1999	35
13	From Genes to Gene Medicines: Recent Advances in Nonviral Gene Delivery Critical Reviews in Therapeutic Drug Carrier Systems ·Alain Rolland	1998	174
14	Target Specific Optimization of Cationic Lipid-Based Systems for Pulmonary Gene Therapy Pharmaceutical Research ·Hayden Street South, Paul Blezinger, Ravi Pillai, J.G. Duguid, Bruce Freimark, Alain Rolland	1998	37
15	A Physicochemical Approach for Predicting the Effectiveness of Peptide-Based Gene Delivery Systems for Use in Plasmid-Based Gene Therapy Biophysical Journal ·J.G. Duguid, Cynthia Li, Mei Shi, Mark Logan, Hector W. Alila, Alain Rolland, Eric Tomlinson, James T. Sparrow, Louis C. Smith	1998	79
16	Biodistribution and Gene Expression of Lipid/Plasmid Complexes after Systemic Administration Human Gene Therapy ·Ram I. Mahato, Khursheed Anwer, J For, Clare Meaney, Carol Jones, Manpreet S. Wadhwa, Mark Logan, Martha French, Alain Rolland	1998	131
17	Pharmaceutical particulate carriers : Therapeutic applications Marcel Dekker eBooks ·Alain Rolland	1993	79
18	Behavioural Effects of the American Traditional PlantEschscholzia californica: Sedative and Anxiolytic Properties Planta Medica ·Alain Rolland, Jacques Fleurentin, Marie‐Claire Lanhers, Chafique Younos, René Misslin, F. Mortier, Neshat Mehdi	1991	85
19	Tert-Butyl Hydroperoxide-Induced Injury In Isolated Rat Hepatocytes: A Model for Studying Anti-Hepatotoxic Crude Drugs Planta Medica ·Michel Joyeux, Alain Rolland, Jacques Fleurentin, F. Mortier, Pierre Dorfman	1990	79
20	A new immunoreagent for cell labeling CD3 monoclonal antibody covalently coupled to fluorescent polymethacrylic nanoparticles Journal of Immunological Methods ·Dominique Bourel, Alain Rolland, Roger Le Verge, B Genetet	1988	21

About Alain Rolland

Alain Rolland is a scholar working on Pharmaceutical Science, Toxicology, Molecular Biology, Immunology and Biomaterials, having authored 134 papers that have together received 5.5k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (32 papers), Virus-based gene therapy research (20 papers), Perovskite Materials and Applications (14 papers), Immunotherapy and Immune Responses (12 papers), Advanced biosensing and bioanalysis techniques (10 papers), Influenza Virus Research Studies (9 papers), Nanoparticle-Based Drug Delivery (8 papers) and Cytomegalovirus and herpesvirus research (7 papers). The work is most often cited by research in Pharmaceutical Science (408 citations), Toxicology (158 citations), Molecular Biology (2.8k citations), Biomaterials (485 citations) and Genetics (955 citations). Alain Rolland has collaborated with scholars based in France, United States and United Kingdom. Frequent co-authors include Jijun Wang, Russell J. Mumper, Ram I. Mahato, Khursheed Anwer, Eric Tomlinson, Fiona MacLaughlin, Seán M. Sullivan, Larry Smith, D. Mencaraglia and Jean‐Paul Kleider. Their work appears in journals such as Pharmaceutical Research, Journal of Controlled Release, Human Gene Therapy, International Journal of Pharmaceutics and Vaccine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact